vs
百利高（PRGO）与XPO, Inc.（XPO）财务数据对比。点击上方公司名可切换其他公司
XPO, Inc.的季度营收约是百利高的1.8倍（$2.0B vs $1.1B），XPO, Inc.净利率更高（2.9% vs -127.8%，领先130.7%），XPO, Inc.同比增速更快（4.7% vs -2.5%），过去两年百利高的营收复合增速更高（1.3% vs -0.1%）
百利高（Perrigo）是一家注册于爱尔兰的非处方仿制药生产商，主打自有品牌OTC药品业务。公司70%的净销售额来自美国医疗市场，为优化税务布局将法定总部设在爱尔兰，该地区销售额仅占总营收的0.6%，2013年曾完成美国历史上第六大企业税收倒置交易。
XPO Inc.（原XPO物流）是美国交通运输企业，主营北美区域零担货运业务，总部位于康涅狄格州格林尼治，全球共设592个运营网点。作为北美第二大零担货运服务商，其服务覆盖99%的美国邮政编码区域。
PRGO vs XPO — 直观对比
营收规模更大
XPO
是对方的1.8倍
$1.1B
营收增速更快
XPO
高出7.2%
-2.5%
净利率更高
XPO
高出130.7%
-127.8%
两年增速更快
PRGO
近两年复合增速
-0.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $2.0B |
| 净利润 | $-1.4B | $59.0M |
| 毛利率 | 32.6% | — |
| 营业利润率 | -116.0% | 7.1% |
| 净利率 | -127.8% | 2.9% |
| 营收同比 | -2.5% | 4.7% |
| 净利润同比 | -3093.9% | -21.3% |
| 每股收益（稀释后） | $-10.23 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PRGOXPO
| Q4 25 | $1.1B | $2.0B | ||
| Q3 25 | $1.0B | $2.1B | ||
| Q2 25 | $1.1B | $2.1B | ||
| Q1 25 | $1.0B | $2.0B | ||
| Q4 24 | $1.1B | $1.9B | ||
| Q3 24 | $1.1B | $2.1B | ||
| Q2 24 | $1.1B | $2.1B | ||
| Q1 24 | $1.1B | $2.0B |
净利润PRGOXPO
| Q4 25 | $-1.4B | $59.0M | ||
| Q3 25 | $7.5M | $82.0M | ||
| Q2 25 | $-8.4M | $106.0M | ||
| Q1 25 | $-6.4M | $69.0M | ||
| Q4 24 | $-44.4M | $75.0M | ||
| Q3 24 | $-21.0M | $95.0M | ||
| Q2 24 | $-108.4M | $150.0M | ||
| Q1 24 | $2.0M | $67.0M |
毛利率PRGOXPO
| Q4 25 | 32.6% | — | ||
| Q3 25 | 36.1% | — | ||
| Q2 25 | 34.4% | — | ||
| Q1 25 | 37.6% | — | ||
| Q4 24 | 33.9% | — | ||
| Q3 24 | 37.2% | — | ||
| Q2 24 | 37.0% | — | ||
| Q1 24 | 33.1% | — |
营业利润率PRGOXPO
| Q4 25 | -116.0% | 7.1% | ||
| Q3 25 | 7.0% | 7.8% | ||
| Q2 25 | 4.3% | 9.5% | ||
| Q1 25 | 4.5% | 7.7% | ||
| Q4 24 | 10.0% | 7.8% | ||
| Q3 24 | 7.4% | 8.6% | ||
| Q2 24 | -2.5% | 9.5% | ||
| Q1 24 | -5.1% | 6.8% |
净利率PRGOXPO
| Q4 25 | -127.8% | 2.9% | ||
| Q3 25 | 0.7% | 3.9% | ||
| Q2 25 | -0.8% | 5.1% | ||
| Q1 25 | -0.6% | 3.5% | ||
| Q4 24 | -3.9% | 3.9% | ||
| Q3 24 | -1.9% | 4.6% | ||
| Q2 24 | -10.2% | 7.2% | ||
| Q1 24 | 0.2% | 3.3% |
每股收益（稀释后）PRGOXPO
| Q4 25 | $-10.23 | $0.49 | ||
| Q3 25 | $0.05 | $0.68 | ||
| Q2 25 | $-0.06 | $0.89 | ||
| Q1 25 | $-0.05 | $0.58 | ||
| Q4 24 | $-0.32 | $0.63 | ||
| Q3 24 | $-0.15 | $0.79 | ||
| Q2 24 | $-0.79 | $1.25 | ||
| Q1 24 | $0.01 | $0.56 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $310.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.9B | $1.9B |
| 总资产 | $8.5B | $8.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PRGOXPO
| Q4 25 | — | $310.0M | ||
| Q3 25 | $432.1M | $335.0M | ||
| Q2 25 | $454.2M | $225.0M | ||
| Q1 25 | $409.9M | $212.0M | ||
| Q4 24 | $558.8M | $246.0M | ||
| Q3 24 | $1.5B | $378.0M | ||
| Q2 24 | $542.8M | $250.0M | ||
| Q1 24 | $658.5M | $229.0M |
股东权益PRGOXPO
| Q4 25 | $2.9B | $1.9B | ||
| Q3 25 | $4.4B | $1.8B | ||
| Q2 25 | $4.5B | $1.8B | ||
| Q1 25 | $4.4B | $1.6B | ||
| Q4 24 | $4.3B | $1.6B | ||
| Q3 24 | $4.6B | $1.6B | ||
| Q2 24 | $4.5B | $1.5B | ||
| Q1 24 | $4.7B | $1.3B |
总资产PRGOXPO
| Q4 25 | $8.5B | $8.2B | ||
| Q3 25 | $10.1B | $8.2B | ||
| Q2 25 | $10.1B | $8.1B | ||
| Q1 25 | $9.8B | $7.9B | ||
| Q4 24 | $9.6B | $7.7B | ||
| Q3 24 | $11.2B | $7.9B | ||
| Q2 24 | $10.4B | $7.7B | ||
| Q1 24 | $10.6B | $7.6B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $175.4M | — |
| 自由现金流经营现金流 - 资本支出 | $148.6M | — |
| 自由现金流率自由现金流/营收 | 13.4% | — |
| 资本支出强度资本支出/营收 | 2.4% | 5.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $145.1M | — |
8季度趋势，按日历期对齐
经营现金流PRGOXPO
| Q4 25 | $175.4M | — | ||
| Q3 25 | $51.7M | $371.0M | ||
| Q2 25 | $75.9M | $247.0M | ||
| Q1 25 | $-64.5M | $142.0M | ||
| Q4 24 | $312.6M | $189.0M | ||
| Q3 24 | $42.2M | $264.0M | ||
| Q2 24 | $9.5M | $210.0M | ||
| Q1 24 | $-1.4M | $145.0M |
自由现金流PRGOXPO
| Q4 25 | $148.6M | — | ||
| Q3 25 | $29.8M | $215.0M | ||
| Q2 25 | $56.7M | $51.0M | ||
| Q1 25 | $-90.0M | $-57.0M | ||
| Q4 24 | $274.9M | $23.0M | ||
| Q3 24 | $15.1M | $137.0M | ||
| Q2 24 | $-18.9M | $20.0M | ||
| Q1 24 | $-26.5M | $-161.0M |
自由现金流率PRGOXPO
| Q4 25 | 13.4% | — | ||
| Q3 25 | 2.9% | 10.2% | ||
| Q2 25 | 5.4% | 2.5% | ||
| Q1 25 | -8.6% | -2.9% | ||
| Q4 24 | 24.2% | 1.2% | ||
| Q3 24 | 1.4% | 6.7% | ||
| Q2 24 | -1.8% | 1.0% | ||
| Q1 24 | -2.4% | -8.0% |
资本支出强度PRGOXPO
| Q4 25 | 2.4% | 5.3% | ||
| Q3 25 | 2.1% | 7.4% | ||
| Q2 25 | 1.8% | 9.4% | ||
| Q1 25 | 2.4% | 10.2% | ||
| Q4 24 | 3.3% | 8.6% | ||
| Q3 24 | 2.5% | 6.2% | ||
| Q2 24 | 2.7% | 9.1% | ||
| Q1 24 | 2.3% | 15.2% |
现金转化率PRGOXPO
| Q4 25 | — | — | ||
| Q3 25 | 6.89× | 4.52× | ||
| Q2 25 | — | 2.33× | ||
| Q1 25 | — | 2.06× | ||
| Q4 24 | — | 2.52× | ||
| Q3 24 | — | 2.78× | ||
| Q2 24 | — | 1.40× | ||
| Q1 24 | -0.70× | 2.16× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
XPO
| North American LTL | $1.2B | 58% |
| European Transportation | $844.0M | 42% |
